Skip to content

Clinical trials

Terminated Phase 2 Central Nervous System Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 2 Status: Terminated Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20032
20041
20051
20062
20101
20121
20131
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Ali Altunkaya1
Burzynski Research Institute1
Children's Hospital of Philadelphia1
Dartmouth-Hitchcock Medical Center1
Incyte Corporation1
Jonsson Comprehensive Cancer Center1
M.D. Anderson Cancer Center1
Monica Thakar1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms16
Glioblastoma8
Gliosarcoma7
Brain Neoplasms5
Astrocytoma2
Oligodendroglioma2
Brain Edema1
Drug-Related Side Effects and Adverse Reactions1
Fatigue1
Glioma1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.